Cough syrup scandal: India production halted after Gambia child deaths
Written by Olarotimi Oshin on October 13, 2022
Indian health officials have ordered a maker of cough syrups to halt production after they were linked to the deaths of children in The Gambia.
Maiden Pharmaceuticals broke rules “across its manufacturing and testing activities,” Indian regulators found.
The World Health Organization (WHO) issued a global alert over four of Maiden’s cough syrups linked to the deaths of almost 70 children.
BBC reports that Investigations are currently under way in India and The Gambia.
Regulators said that they had suspended all manufacturing activities at the New Delhi-based firm after finding it had broken a number of safety rules.
Uploaded by – ADULEYE OYINKANSOLA